Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 13/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 7/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1797219 | 0.90 | ALDH1A1 (0.59) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1797214 | 0.81 | ALDH1A1 (0.50) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1796876 | 0.81 | ALDH1A1 (0.50) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1795054 | 0.77 | ALDH1A1 (0.53) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1800640 | 0.77 | ALDH1A1 (0.72) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1795357 | 0.75 | KDM4E (0.46) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1797622 | 0.75 | ALDH1A1 (0.42) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL3611687 | 0.75 | ALDH1A1 (0.57) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1796249 | 0.74 | ALDH1A1 (0.53) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL1797144 | 0.74 | SERPINE1 (0.56) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951806-B2 | Plasminogen activator inhibitor-1 inhibitor | RENASCIENCE CO., LTD. (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090124620-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | RENASCIENCE CO., LTD. (JP) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124620-A1 | PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR | SERPINE1, SERPINC1, SERPINB1 | ALDH1A1 800/4885HPGD 920/4885LMNA 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.